VEGFA and obesity due to melanocortin 4 receptor deficiency: Cao et al. (2023) demonstrated that injectable hydrogels containing micelles can treat persistent wounds in patients with diabetes and obesity by providing a controlled release of VEGF and antimicrobial drugs [7].